|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total Current Assets | ||||||
| Deferred offering costs | ||||||
| Forward Purchase Agreement (FPA) asset | ||||||
| Investment held in Trust Account | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | ||||||
| Current liabilities | ||||||
| Accrued expenses | ||||||
| Accrued offering costs | ||||||
| Accrued expenses and accounts payable | ||||||
| Due to related party | ||||||
| Promissory note—related party | ||||||
| Convertible promissory note | ||||||
| Total Current Liabilities | ||||||
| Forward Purchase Agreement (FPA) liability | ||||||
| Warrant liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| Total Liabilities | ||||||
| Class A redeemable ordinary shares subject to possible redemption, $0.0001 par value, 400,000,000 shares authorized; 41,400,000 shares at $10.06 and $10.00 per share redemption value as of September 30, 2022 and December 31, 2021, respectively | ||||||
| Shareholders' Deficit | ||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding | ||||||
| Common stock value | ||||||
| Common Class A | ||||||
| Common Class B | ||||||
| Class B non-redeemable ordinary shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total Shareholders' Deficit | ||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT |
Loading...
